This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bertina RM, Koeleman BPC, Koster T, et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C (letter). Nature 369:64–67
Dahlbäck B, Hildebrand B (1994) Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 91:1396–1400
Emmerich J, Poirier O, Evans A, et al (1995) Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance. Lancet 345:321
Forsyth PD, Dolan G (1995) Activated protein C resistance in cases of cerebral infarction. Lancet 345:795
Majerus PW (1994) Bad bloody by mutation. Nature 369: 14–15
Martinelli I, Landi G, Merati G, et al (1996) Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost 75:393–394
Rosendaal FR, Koster T, Vandenbroucke JP, et al (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85:1504–1508
Trossaert M, Conrad J, Horellou MH, et al (1995) Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations. Presse Med 24:209–212
About this article
Cite this article
Sánchez del Rio, M., Gómez-Tortosa, E. & Outeriño, J. Cerebral venous thrombosis and activated protein C resistance. J Neurol 243, 727–728 (1996). https://doi.org/10.1007/BF00873981
- Public Health
- Venous Thrombosis
- Cerebral Venous Thrombosis